Market Currents
Nektar Therapeutics (NKTR): Q4 EPS of -$0.24 may not be comparable with consensus of -$0.16....
-
Tuesday, March 1, 2011, 4:21 PM ETNektar Therapeutics (NKTR): Q4 EPS of -$0.24 may not be comparable with consensus of -$0.16. Revenue of $45.3M (+16% Y/Y) beats by $3.8M. Shares +2.7% AH. (PR)
Other date
Latest Earnings Articles
